From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Unity Biotechnology Inc (NASDAQ:UBX) stock has reached a 52-week high, trading at $2.02, signaling a period of robust ...
(RTTNews) - Shares of Unity Biotechnology, Inc. (UBX) are gaining 9% in the pre-market trading after it has announced the appointment of Federico Grossi as Chief Medical Officer. Federico Grossi ...
today strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings a wealth of experience in clinical development ...
NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced ...
SAN FRANCISCO - UNITY Biotechnology, Inc. [NASDAQ:UBX], a biotech firm focused on developing treatments for age-related diseases with a market capitalization of $21.57 million, announced today the ...
11d
Dall'annuncio di un grande colpo, al comunicato sulla trattativa in corso con Dame Sarr, alla conclusione negativa della ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback